283 related articles for article (PubMed ID: 9927210)
1. Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines.
Giamarchi C; Solanas M; Chailleux C; Augereau P; Vignon F; Rochefort H; Richard-Foy H
Oncogene; 1999 Jan; 18(2):533-41. PubMed ID: 9927210
[TBL] [Abstract][Full Text] [Related]
2. [Chromatin remodeling in estrogen-dependent and independent human breast cancer cell lines].
Chailleux C; Giamarchi C; Morales V; Moro F; Richard-Foy H
Ann Endocrinol (Paris); 2000 May; 61(2):130-5. PubMed ID: 10891664
[TBL] [Abstract][Full Text] [Related]
3. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Chalbos D; Philips A; Galtier F; Rochefort H
Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
[TBL] [Abstract][Full Text] [Related]
4. Chromatin remodeling in hormone-dependent and -independent breast cancer cell lines.
Giamarchi C; Chailleux C; Richard-Foy H
Adv Exp Med Biol; 2000; 480():155-61. PubMed ID: 10959422
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells.
Cavailles V; Garcia M; Rochefort H
Mol Endocrinol; 1989 Mar; 3(3):552-8. PubMed ID: 2664475
[TBL] [Abstract][Full Text] [Related]
6. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
[TBL] [Abstract][Full Text] [Related]
7. Two antiestrogens affect differently chromatin remodeling of trefoil factor 1 (pS2) gene and the fate of estrogen receptor in MCF7 cells.
Giamarchi C; Chailleux C; Calligé M; Rochaix P; Trouche D; Richard-Foy H
Biochim Biophys Acta; 2002 Oct; 1578(1-3):12-20. PubMed ID: 12393183
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
Lu D; Kiriyama Y; Lee KY; Giguère V
Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): evidence for an interaction between the two systems.
Panagiotou S; Hatzoglou A; Calvo F; Martin PM; Castanas E
J Cell Biochem; 1998 Dec; 71(3):416-28. PubMed ID: 9831078
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells.
Cavaillès V; Augereau P; Rochefort H
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):203-7. PubMed ID: 8419924
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cathepsin-D and pS2 protein levels in human breast cancer cell lines.
Cappelletti V; Fioravanti L; Miodini P; Di Fronzo G
Tumour Biol; 1996; 17(5):290-8. PubMed ID: 8792855
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of the pS2 gene and estrogen receptor in human breast cancer cells.
Stack G; Kumar V; Green S; Ponglikitmongkol M; Berry M; Rio MC; Nunez AM; Roberts M; Koehl C; Bellocq P
Cancer Treat Res; 1988; 40():185-206. PubMed ID: 2908650
[TBL] [Abstract][Full Text] [Related]
13. Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells.
Cavaillès V; Gompel A; Portois MC; Thénot S; Mabon N; Vignon F
J Mol Endocrinol; 2002 Jun; 28(3):165-75. PubMed ID: 12063183
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
[TBL] [Abstract][Full Text] [Related]
15. Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.
Recchia AG; Vivacqua A; Gabriele S; Carpino A; Fasanella G; Rago V; Bonofiglio D; Maggiolini M
Food Addit Contam; 2004 Feb; 21(2):134-44. PubMed ID: 14754635
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.
Brünner N; Boulay V; Fojo A; Freter CE; Lippman ME; Clarke R
Cancer Res; 1993 Jan; 53(2):283-90. PubMed ID: 8380254
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the proximal estrogen-responsive element of human cathepsin D gene.
Augereau P; Miralles F; Cavaillès V; Gaudelet C; Parker M; Rochefort H
Mol Endocrinol; 1994 Jun; 8(6):693-703. PubMed ID: 7935485
[TBL] [Abstract][Full Text] [Related]
18. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
19. Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor.
Zajchowski DA; Sager R
Mol Endocrinol; 1991 Nov; 5(11):1613-23. PubMed ID: 1664044
[TBL] [Abstract][Full Text] [Related]
20. Chromatin structure and transcriptional regulation of human RAG-1 gene.
Kitagawa T; Mori K; Kishi H; Tagoh H; Nagata T; Kurioka H; Muraguchi A
Blood; 1996 Nov; 88(10):3785-91. PubMed ID: 8916942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
